Literature DB >> 7843466

Glycosaminoglycans of umbilical cord arteries and their alterations in EPH-gestosis.

L Romanowicz1, E Bańkowski, S Jaworski, L Chyczewski.   

Abstract

It was found that the umbilical cord arteries (UCAs) contained several types of glycosaminoglycans (GAGs), including hyaluronic acid and sulphated glycosaminoglycans. EPH-gestosis is accompanied by significant changes in the composition of extracellular matrix of the UCAs. Significant increase in collagen content was found. Total amount of GAGs did not change much but the quantitative ratio between various GAGs distinctly altered. A decrease in hyaluronic acid content and an increase in the amount of sulphated GAGs as well as a diminution of GAGs/collagen ratio were observed. These observations were confirmed by histochemical methods. The significance of these phenomena for collagen fibrillogenesis in the arterial wall is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7843466

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  4 in total

1.  Sphingolipids of human umbilical cord vein and their alteration in preeclampsia.

Authors:  Lech Romanowicz; Edward Bańkowski
Journal:  Mol Cell Biochem       Date:  2010-02-14       Impact factor: 3.396

2.  Lipid compounds of human Wharton's jelly and their alterations in preeclampsia.

Authors:  Lech Romanowicz; Edward Bańkowski
Journal:  Int J Exp Pathol       Date:  2009-10-28       Impact factor: 1.925

Review 3.  Extracellular matrix remodeling of the umbilical cord in pre-eclampsia as a risk factor for fetal hypertension.

Authors:  Lech Romanowicz; Zofia Galewska
Journal:  J Pregnancy       Date:  2010-12-29

4.  Separation and Determination of Fatty Acids from Lipid Fractions by High-Performance Liquid Chromatography: Cholesterol Esters of Umbilical Cord Arteries.

Authors:  Lech Romanowicz; Stefan Jaworski; Zofia Galewska; Tomasz Gogiel
Journal:  Toxicol Mech Methods       Date:  2008-06-23       Impact factor: 2.987

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.